Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4582940)

Published in Fluids Barriers CNS on September 25, 2015

Authors

Amir Ramezani1, Katarina Nägga2, Oskar Hansson3, Johanna Lönn4, Johanna Sjöwall5, Fateme Katoozian6, Sepahdar Mansouri7, Fariba Nayeri8,9

Author Affiliations

1: Department of Neurosurgery, Region Östergötland, University Hospital, Linköping University, Linköping, Sweden. amir.ramezani@regionostergotland.se.
2: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Katarina.nagga@med.lu.se.
3: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. oskar.hansson@med.lu.se.
4: Department of Biomedicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden. johanna.lonn@oru.se.
5: Clinic of Infectious Diseases, Region Östergötland, University Hospital, Linköping University, 58185, Linköping, Sweden. johanna.sjowall@liu.se.
6: The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden. fatemekatouzian@gmail.com.
7: The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden. a.mansouran@gmail.com.
8: Clinic of Infectious Diseases, Region Östergötland, University Hospital, Linköping University, 58185, Linköping, Sweden. fariba.nayeri@regionostergotland.se.
9: The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden. fariba.nayeri@regionostergotland.se.

Articles cited by this

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell (1991) 4.98

Bacterial meningitis--a view of the past 90 years. N Engl J Med (2004) 1.77

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol (1999) 1.43

Retracted Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int (2011) 1.26

Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin Infect Dis (2008) 1.23

Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther (2010) 1.20

Prospective validation of a diagnosis model as an aid to therapeutic decision-making in acute meningitis. Eur J Clin Microbiol Infect Dis (2000) 1.04

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease. PLoS One (2013) 1.01

Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study. J Dermatolog Treat (2002) 1.00

Proteoglycans in the central nervous system: role in development, neural repair, and Alzheimer's disease. IUBMB Life (2013) 0.95

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease. Acta Neurol Scand (2003) 0.94

Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers. J Dermatol Sci (2004) 0.93

High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases. Scand J Infect Dis (2002) 0.91

Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and nonbacterial meningitis. J Infect Dis (2000) 0.91

Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med (2002) 0.89

Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res (1998) 0.89

Sample handling and stability of hepatocyte growth factor in blood samples. Cytokine (2002) 0.88

Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study. Alzheimers Res Ther (2014) 0.87

Hepatocyte growth factor (HGF) in fecal samples: rapid detection by surface plasmon resonance. BMC Gastroenterol (2005) 0.86

An in vitro model for assessment of the biological activity of hepatocyte growth factor. Growth Factors (2007) 0.86

An Antithrombin III product containing biologically active hepatocyte growth factor may be beneficial in deep ulcer infections. Cytokine (2012) 0.84

Characteristics of infections associated with external ventricular drains of cerebrospinal fluid. J Infect (2013) 0.84

Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia. Scand J Infect Dis (2002) 0.83

Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor. Growth Factors (2008) 0.83

Hepatocyte growth factor is a better indicator of therapeutic response than C-reactive protein within the first day of treatment in pneumonia. Chemotherapy (2006) 0.82

Implications of heparan sulfate and heparanase in neuroinflammation. Matrix Biol (2014) 0.82

High hepatocyte growth factor levels in faeces during acute infectious gastroenteritis. Scand J Infect Dis (2003) 0.80

Evaluation of hepatocyte growth factor as a local acute phase response marker in the bowel: the clinical impact of a rapid diagnostic test for immediate identification of acute bowel inflammation. Cytokine (2014) 0.77